Literature DB >> 6095844

Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects.

J L Sadoul, F Chécler, P Kitabgi, W Rostène, F Javoy-Agid, J P Vincent.   

Abstract

Monoiodo [125I-Tyr3]-Neurotensin binding was studied in post mortem substantia nigra from 17 control and 15 parkinsonian subjects. Binding to individual homogenates was decreased by 58%, 49% and 26% at 0.36, 1.4, 5.5 M(-9) concentration of ligand, respectively. Saturation analysis using pooled substantia nigra demonstrated an almost complete loss of the high affinity component of the neurotensin receptor complex, yielding a 24% loss of the total binding capacity, with no alteration of the low affinity component. Similarly an important loss of binding was observed in monoiodo[125I-Tyr3]-Neurotensin autoradiograms of two substantia nigra from parkinsonian subjects. These results support the hypothesis of neurotensin receptors occurring on dopamine cell bodies and/or dendrites in human substantia nigra. Role of neurotensin may be of importance in the regulation of dopamine pathway involved in parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095844     DOI: 10.1016/s0006-291x(84)80381-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

2.  Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.

Authors:  D Nouel; M P Faure; J A St Pierre; R Alonso; R Quirion; A Beaudet
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

3.  Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

Authors:  D Herve; J P Tassin; J M Studler; C Dana; P Kitabgi; J P Vincent; J Glowinski; W Rostene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects.

Authors:  S S Wolf; T M Hyde; R C Saunders; M M Herman; D R Weinberger; J E Kleinman
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.

Authors:  A Schotte; J E Leysen; P M Laduron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

6.  The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop.

Authors:  L Ferraro; T Antonelli; W T O'Connor; K Fuxe; P Soubrié; S Tanganelli
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

7.  Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.

Authors:  Maria Lazarova; Andrey Popatanasov; Radoslav Klissurov; Svetlana Stoeva; Tamara Pajpanova; Reni Kalfin; Lyubka Tancheva
Journal:  J Mol Neurosci       Date:  2018-10-30       Impact factor: 3.444

Review 8.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

9.  Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.

Authors:  Nancy G Hernandez-Chan; Michael J Bannon; Carlos E Orozco-Barrios; Lourdes Escobedo; Sergio Zamudio; Fidel De la Cruz; Jose L Gongora-Alfaro; Juan Armendáriz-Borunda; David Reyes-Corona; Armando J Espadas-Alvarez; Yazmin M Flores-Martínez; Jose Ayala-Davila; Maria E Hernandez-Gutierrez; Lenin Pavón; Refugio García-Villegas; Rasajna Nadella; Daniel Martinez-Fong
Journal:  J Biomed Sci       Date:  2015-07-22       Impact factor: 8.410

10.  Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.

Authors:  David Reyes-Corona; Nallely Vázquez-Hernández; Lourdes Escobedo; Carlos E Orozco-Barrios; Jose Ayala-Davila; Mario Gil Moreno; Miriam E Amaro-Lara; Yazmin M Flores-Martinez; Armando J Espadas-Alvarez; Manuel A Fernandez-Parrilla; Juan A Gonzalez-Barrios; M E Gutierrez-Castillo; Ignacio González-Burgos; Daniel Martinez-Fong
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.